Indicated for: uterine contractions; postpartum hemorrhage
Route of administration: injectable
Substance: methylergometrine (uterotonic)
ATC: G02AB01 (Genito urinary system and sex hormones | Uterotonics | Ergot alkaloids)
Methylergometrine is a medication used to control postpartum bleeding by helping the uterus contract after childbirth. It is often administered immediately after the placenta is delivered to reduce the risk of severe maternal hemorrhage.
The medication can be given orally, intramuscularly, or intravenously, depending on medical instructions and the urgency of the situation. Administration must occur under strict medical supervision, especially in women with cardiovascular conditions.
Possible side effects include nausea, high blood pressure, abdominal pain, and, in rare cases, heart problems or seizures. For this reason, patients must be closely monitored during treatment.
Methylergometrine is an effective tool for managing postnatal bleeding and ensuring maternal safety, but it must be used cautiously and under controlled conditions to minimize risks.